CRO
CDMO
CMO
Inspection Service
Scientific Customized Peptides
General linear peptide synthesis
Long peptide synthesis
Cyclic peptide synthesis (staple peptide)
Cyclic peptide synthesis (disulfide ring formation)
Stable isotope labeling peptide synthesis
Glycopeptides
Polypeptide modification
Peptide library synthesis
View all
Linker Synthesis Service
ADC Linker Synthesis Service
PDC Drug Synthesis Services
View all
FTE Services
Sequence and synthesis circuit design
Pilot-process optimization-mass production
Real-time progress report without time zone
View all
Learn more
Popular peptides
Catalog peptides
Beauty peptides
Drug peptide intermediates and impurities
Linker
Synthesis of unnatural amino acids and other blocks
RGD,RAD Peptide
Ac-RADARADARADARADAYKKIIKKLRGDSP-NH2
Cell Adhesive Peptide [RGDC]
N-{Orn}-TA-c(RG-{DPhe}-K)
cyclo[RGDfK(Biotin)]
c{RGDfK(N3)}
Axltide
cyclo{RG-{DPhe}-K(Mpa)}
Fibronectin Adhesion-Promoting Peptide
View all
Targeted Peptide
Cys-Angiopep-2
Angiopep-2-SH
TfR Targeting Peptide、TfR-T12
Dcpep
GE11
G280-9
GPC3
c(RGD-DPhe-K)
View all
Peptide Tag
HA 12CA5 Epitope
Rhodopsin Epitope Tag
X-press
VSV-G Tag
V5 tag
Cys-T7 tag
T7 tag-Cys
T7 tag
View all
Learn more
Home / Peptide products / Cardiovascular / Ornipressin
Filters
Popular peptides
RGD,RAD Peptide
Targeted Peptide
Peptide Tag
Cell-penetrating Peptides
Substrate Peptide
Inhibitor peptides
Amyloid β-Protein
Catalog peptides
Beauty peptides
Anti-aging
Anti-inflammatory
Repair
Moisturizing
Whitening
Hair care
Drug peptide intermediates and impurities
Neoplasm
Diabetes mellitus
Cardiovascular
Gonozoa
Anti-infection
Osteoporosis
Other
Linker
Linker
Synthesis of unnatural amino acids and other blocks
Fmoc protects unnatural amino acids
Ornipressin
Name
Ornipressin
Molecular structural formula
Purity
95%
CAS Number
3397-23-7
Formula
C45H63N13O12S2
MW
1042.19
Target
others
Sequence
Cys-Tyr-Phe-Gln-Asn-Cys-Pro-{Orn}-Gly-NH2 (Disulfide bridge: Cys1-Cys6)
Sequence Shortening
CYFQNCP-{Orn}-G-NH2 (Disulfide bridge: Cys1-Cys6)
InChIKey
MUNMIGOEDGHVLE-LGYYRGKSSA-N
Solubility in water
75 mg/mL
References
[1]. Fruhstorfer H, et al. Dose-response relation of ornipressin with regard to vasoconstriction in human skin. Br J Anaesth. 1994 Aug;73(2):220-4. [2]. De Kock M, et al. Ornipressin (Por 8): An efficient alternative to counteract hypotension during combined general/epidural anesthesia. Anesth Analg. 2000 Jun;90(6):1301-7.
* All products on our website are for scientific research and cannot be used in human body
Product details
Data download

Ornipressin is a potent vasoconstrictor, hemostatic and renal agent.